Has Eugene Brown, MD received payments from drug or device companies?

Yes. Drug and device makers reported $27,510 in general payments to Eugene Brown, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eugene Brown, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eugene Brown, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eugene Brown, MD

Otolaryngology · Charleston, SCNPI 1245238930

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Neurent Medical Limited accounts for 89.3% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $15,048, more than ten times the $469 reported in 2019. Among otolaryngology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,510in general payments, 2019–2025

Across 65 payments — averaging $423.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neurent Medical Limited$25K
Inspire Medical Systems, Inc.$1K
Stryker$520
Covidien LP$375
Medtronic$211
Aerin Medical Inc.$170
plus $596 from 14 others

$87,638in research payments, 2019–2025

Across 9 payments — averaging $9737.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Covidien LP$88K

$32,760in ownership & investment interests, 2019–2025

Across 7 payments — averaging $4680.00 each. An ownership or investment interest held by the physician or an immediate family member.

The North Carolina Mutual Wholesale Drug Company Inc$33K

What the payments were for

Consulting fees$9,37534%
Travel & lodging$15,50056%
Food & beverage$2,63610%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neurent Medical Limited	25	$24,561
Inspire Medical Systems, Inc.	4	$1,076
Stryker	6	$520
Covidien LP	1	$375
Medtronic(2 entities)	3	$211
Aerin Medical Inc.	2	$170
Regeneron Healthcare Solutions, Inc.	3	$88
Intersect ENT, Inc.	2	$67
Sanofi	2	$60
Optinose US, Inc.	3	$58
Itamar Medical Inc	1	$56
Takeda Pharmaceuticals U.S.A., Inc.	2	$55
Hikma Pharmaceuticals USA	3	$48
Genentech USA, Inc.	1	$29
Merck	1	$29
GSK	2	$26
Grifols USA, LLC	1	$24
Blueprint Medicines Corporation	1	$22
Pharming Healthcare, Inc.	1	$19
AstraZeneca	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,510 in reported general payments places this provider in the 95th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$219,337

Medicare patients

667

Services billed

2,673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	77	$3,457
Azelastine Hcl	55	$1,477
Mometasone Furoate	12	$880
Fluticasone Propionate	60	$782
Famotidine	63	$746
Cefdinir	18	$311
Doxycycline Hyclate	19	$259
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	21	$237
Omeprazole	29	$204
Amitriptyline Hcl	17	$142
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	26	$100
Prednisone	32	$69
Meloxicam	16	$37
Ondansetron Hcl	20	$35
Montelukast Sodium	13	$32

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charleston

Shaun NguyenCharleston$973K
Rodney SchlosserCharleston$382K
Zachary SolerCharleston$67K
Jason NewmanCharleston$26K
Joshua HornigCharleston$25K
Ashli OrourkeCharleston$21K
Alexandra KejnerCharleston$19K
Evan GraboyesCharleston$18K
Mohamed AbdelwahabCharleston$15K
Jeffrey HoultonCharleston$11K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →